Telo Genomics Corp. TDSGF

TDSGF Company Overview

Telo Genomics Corp. is a clinical-stage biotechnology company focused on the development and commercialization of proprietary technologies for the early detection, diagnosis, and prognostication of cancer and other age-related diseases. The company operates primarily within the biotechnology and molecular diagnostics industries, with an emphasis on genomic analysis and personalized medicine.

The company’s core technology, known as TeloView®, is designed to measure three-dimensional telomere architecture within cells, which is associated with genomic instability and disease progression. Telo Genomics was founded as a spin-out from academic research in Canada and has evolved from a research-focused entity into a translational diagnostics company advancing laboratory-developed tests and pursuing regulatory pathways and commercial partnerships.